| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 30/09/2005 | 00:27 | PR Newswire (US) | Guilford Pharmaceuticals Stockholders Vote to Approve MGI PHARMA Merger | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 01/09/2005 | 13:00 | Business Wire | MGI PHARMA and Guilford Pharmaceuticals Announce Expiration of the Hart-Scott-Rodino Waiting Period | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 08/08/2005 | 16:11 | PR Newswire (US) | Guilford Pharmaceuticals Reports 2005 Second Quarter Results | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 08/08/2005 | 14:45 | PR Newswire (US) | Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005 | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 24/05/2005 | 21:44 | PR Newswire (US) | Guilford Pharmaceuticals Implements Strategic Reorganization to Align Resources With Corporate Strategy | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 18/05/2005 | 21:00 | PR Newswire (US) | Guilford Pharmaceuticals Presents New NAALADase Inhibitor Data in Chemotherapy-Induced Neuropathy at ASCO | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 17/05/2005 | 21:39 | PR Newswire (US) | Guilford Pharmaceuticals Announces Promising Results at ASCO in Study of Newly Diagnosed High Grade Malignant Glioma | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 11/05/2005 | 17:01 | PR Newswire (US) | AGGRASTAT(R) Injection Strategy Trial Data Published in JAMA | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 09/05/2005 | 15:42 | PR Newswire (US) | Guilford Pharmaceuticals Reports 2005 First Quarter Results | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 09/05/2005 | 14:45 | PR Newswire (US) | Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005 | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 21/04/2005 | 20:07 | PR Newswire (US) | Guilford Pharmaceuticals Restarts AQUAVAN(R) Clinical Development Program | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 06/04/2005 | 14:45 | PR Newswire (US) | Guilford Pharmaceuticals to Host Webcast Outlining New Corporate Strategy | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 24/03/2005 | 18:04 | PR Newswire (US) | Guilford Pharmaceuticals Announces Phase III AQUAVAN(R) Trial Meets Primary Endpoint | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 08/03/2005 | 17:03 | PR Newswire (US) | Guilford Pharmaceuticals: AGGRASTAT(R) Injection Clinical Data Presented at American College of Cardiology Annual Meeting | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 01/03/2005 | 21:55 | PR Newswire (US) | Guilford Pharmaceuticals Reports 2004 Year-End Financial Results | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 01/03/2005 | 13:45 | PR Newswire (US) | Guilford Pharmaceuticals to Announce 2004 Year-End Financial Results on Tuesday, March 1, 2005 | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 17/12/2004 | 23:30 | PR Newswire (US) | Guilford Pharmaceuticals Completes Sale and Leaseback and Receives $19.4 Million in Net Proceeds | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 02/12/2004 | 14:45 | PR Newswire (US) | Guilford Pharmaceuticals to Acquire ProQuest Pharmaceuticals; Guilford to Obtain Exclusive Worldwide Ownership of AQUAVAN(R) Pro | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 22/11/2004 | 15:03 | PR Newswire (US) | Guilford Pharmaceuticals Presents New GLIADEL(R) Wafer Data at the Society for Neuro-Oncology Annual Meeting | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 17/11/2004 | 23:30 | PR Newswire (US) | Guilford Pharmaceuticals Announces Equity Compensation Arrangement With Dean J. Mitchell Pursuant to NASDAQ Rules | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 17/11/2004 | 14:01 | PR Newswire (US) | Dean J. Mitchell Appointed President and Chief Executive Officer of Guilford Pharmaceuticals | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 12/11/2004 | 16:58 | PR Newswire (US) | AGGRASTAT(R) Strategy Trial Data Presented At American Heart Association Annual Meeting | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 08/11/2004 | 18:11 | PR Newswire (US) | Guilford Pharmaceuticals Reports 2004 Third Quarter Results | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 05/11/2004 | 14:30 | PR Newswire (US) | Guilford Pharmaceuticals to Announce Third Quarter 2004 Financial Results on Monday, November 8, 2004 | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 27/09/2004 | 16:33 | PR Newswire (US) | Guilford Pharmaceuticals Announces Orphan Drug Designation for GLIADEL(R) Wafer; Market Exclusivity for GLIADEL(R) Extends Until | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 22/09/2004 | 16:03 | PR Newswire (US) | Guilford to Present at UBS Global Life Sciences Conference | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 20/09/2004 | 17:05 | PR Newswire (US) | Guilford Pharmaceuticals Begins Phase III Clinical Trials of AQUAVAN(R) Injection | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 17/09/2004 | 16:00 | PR Newswire (US) | Guilford Pharmaceuticals Receives $6 Million For Rights to Polymer Drug Delivery Patents | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 14/09/2004 | 19:00 | PR Newswire (US) | Guilford Pharmaceuticals Receives European Marketing Authorization for Expanded Use of GLIADEL(R) Wafer | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 01/09/2004 | 15:58 | PR Newswire (US) | Guilford Pharmaceuticals Announces Craig R. Smith, M.D. Will Retire as Chairman, President and Chief Executive Officer | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |